MolNFT v1 · #69798 · protein
Discovery of (thienopyrimidin-2-YL)AMINOPYRIMIDINES as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3- KINASE/MTOR inhibitors for the treatment of cancer
3L17: “Discovery of (thienopyrimidin-2-YL)AMINOPYRIMIDINES as potent, selective, and orally available pan-PI3-kinase…”. X-ray diffraction. MolNFT v1 #69798 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3L17
- Type
- protein
- Length
- 841 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P48736
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 841 | — | P48736 |
Compared structures
- 3L17 · Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P48736
- Elsewhere: RCSB PDB 3L17 · PDBe 3L17 · UniProt P48736
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.